Skip to main content

Ductal Adenocarcinoma

  • Chapter
  • First Online:
Imaging and Pathology of Pancreatic Neoplasms

Abstract

Ductal adenocarcinoma is the most common primary malignancy of the pancreas, accounting for about 80 % of malignant pancreatic tumors. It is a highly aggressive tumor with an overall 5-year survival rate less than 5 %. Prognosis and treatment depend on whether the tumor is resectable or nonresectable, which mostly depends on the time of diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Schima W, Ba-Ssalamah A, Kolblinger C et al (2007) Pancreatic adenocarcinoma. Eur Radiol 17(3):638–649

    Article  PubMed  Google Scholar 

  2. Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas, 2nd edn. Armed Forces Institute of Pathology, Washington, DC

    Google Scholar 

  3. O’Connor TP, Wade TP, Sunwoo YC et al (1992) Small cell undifferentiated carcinoma of the pancreas. Report of a patient with tumor marker studies. Cancer 70:1514–1519

    Article  PubMed  Google Scholar 

  4. Chong I, Cunningham D (2011) Chapter 93: Pancreatic cancer. In: Harrison’s principles of internal medicine, 18th edn. McGraw Hill, New York

    Google Scholar 

  5. Sahani DV, Shan ZK, Catalano OA et al (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23(1):23–33

    Article  PubMed  Google Scholar 

  6. Wong JC, Lu DS et al (2008) Staging of pancreatic adenocarcinoma by imaging studies. Clin Gastroenterol Hepatol 6:1301–1308

    Article  PubMed  Google Scholar 

  7. Bosman FT, World Health Organization, International Agency for Research on Cancer (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer, Lyon

    Google Scholar 

  8. Lüttges J, Vogel I, Menke M et al (1998) The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 433(3):237–242

    Article  PubMed  Google Scholar 

  9. Esposito I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15(6):1651–1660

    Article  PubMed  Google Scholar 

  10. Schlitter AM, Esposito I (2010) Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancer 2(4):2001–2010

    Article  Google Scholar 

  11. Jamieson NB, Chan NI, Foulis AK et al (2013) The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg 17(3):511–521

    Article  PubMed  Google Scholar 

  12. Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13(7):1337–1344

    Article  PubMed  Google Scholar 

  13. Adsay NV, Basturk O, Altinel D et al (2009) The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 22(1):107–112

    Article  PubMed Central  PubMed  Google Scholar 

  14. Paik KY, Choi SH, Heo JS et al (2011) Solid tumors of the pancreas can put on a mask through cystic change. World J Surg Oncol 9:79

    Article  PubMed Central  PubMed  Google Scholar 

  15. Erkan M, Hausmann S, Michalski CW et al (2012) How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol 3:389

    Article  PubMed Central  PubMed  Google Scholar 

  16. Bagci P, Andea AA, Basturk O et al (2012) Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: a potential microscopic mimic of non-invasive ductal neoplasia. Mod Pathol 25(3):439–448

    Article  PubMed  Google Scholar 

  17. Kelly PJ, Shinagare S, Sainani N et al (2012) Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma. Am J Surg Pathol 36(5):696–701

    Article  PubMed  Google Scholar 

  18. Kosmahl M, Pauser U, Anlauf M et al (2005) Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform. Mod Pathol 18(9):1157–1164

    Article  PubMed  Google Scholar 

  19. Martinez-Noguera A, D’Onofrio M (2007) Ultrasonography of the pancreas. 1. Conventional imaging. Abdom Imaging 32:136–149

    Article  CAS  PubMed  Google Scholar 

  20. Procacci C, Biasiutti C, Carbognin G et al (2001) Pancreatic neoplasms and tumor-like conditions. Eur Radiol 11(Suppl 2):S167–S192

    Google Scholar 

  21. Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) – update 2008. Ultraschall Med 29:28–44

    Article  CAS  PubMed  Google Scholar 

  22. Piscaglia F, Nolsoe C, Dietrich CF et al (2012) The EFSUMB Guidelines and recommendations on the clinical practice of contrast-enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 33(1):33–59

    Article  CAS  PubMed  Google Scholar 

  23. Park HS, Lee JM, Choi HK et al (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30:586–595

    Article  PubMed  Google Scholar 

  24. D’Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7(2):257–273

    Google Scholar 

  25. Minniti S, Bruno C, Biasiutti C et al (2003) Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma. J Clin Ultrasound 31:175–182

    Article  PubMed  Google Scholar 

  26. Niederau C, Grendell JH (1992) Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 7:66–86

    Article  CAS  PubMed  Google Scholar 

  27. Karlson BM, Ekbom A, Lindgren PG et al (1999) Abdominal US for diagnosis of pancreatic tumor: prospective cohort analysis. Radiology 213:107–111

    Article  CAS  PubMed  Google Scholar 

  28. Dietrich CF, Hocke M, Gallotti A, D’Onofrio M (2012) Solid pancreatic tumors. In: D’Onofrio M (ed) Ultrasonography of the pancreas. Springer, Italy, pp 93–110

    Chapter  Google Scholar 

  29. Hohl C, Schmidt T, Honnef D et al (2007) Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging 32:150–160

    Article  CAS  PubMed  Google Scholar 

  30. Bertolotto M, D’Onofrio M, Martone E et al (2007) Ultrasonography of the pancreas. 3. Doppler imaging. Abdom Imaging 32(2):161–170

    Article  CAS  PubMed  Google Scholar 

  31. Angeli E, Venturini M, Vanzulli A et al (1997) Color-Doppler imaging in the assessment of vascular involvement by pancreatic carcinoma. Am J Roentgenol 168:193–197

    Article  CAS  Google Scholar 

  32. Menges M, Lerch MM, Zeitz M (2000) The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc 52:74–77

    Article  CAS  PubMed  Google Scholar 

  33. Dearden JC, Ayaru L, Wong V et al (2004) The double duct sign. Lancet 364:302

    Article  CAS  PubMed  Google Scholar 

  34. Tanaka S, Nakao M, Ioka T et al (2010) Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology 254:965–972

    Article  PubMed  Google Scholar 

  35. Hirche TO, Ignee A, Barreiros AP et al (2008) Indications and limitations of endoscopic ultrasound elastography for evaluation of focal pancreatic lesions. Endoscopy 40:910–917

    Article  CAS  PubMed  Google Scholar 

  36. Nightingale K, Soo MS, Nightingale R et al (2002) Acoustic radiation force impulse imaging, in vivo demonstration of clinical feasibility. Ultrasound Med Biol 28:227–235

    Article  PubMed  Google Scholar 

  37. Garra BS (2007) Imaging and estimation of tissue elasticity by ultrasound. Ultrasound Q 23:255–268

    Article  PubMed  Google Scholar 

  38. Giovannini M, Botelberge T, Bories E et al (2009) Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. World J Gastroenterol 15:1587–1593

    Article  PubMed Central  PubMed  Google Scholar 

  39. Saftoiu A, Vilmann P, Gorunescu F et al (2011) European EUS Elastography Multicentric Study Group. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy 43:596–603

    Article  CAS  PubMed  Google Scholar 

  40. Gallotti A, D’Onofrio M, Pozzi Mucelli R (2010) Acoustic radiation force impulse (ARFI) technique in the ultrasound study with Virtual Touch tissue quantification of the superior abdomen. Radiol Med 115:889–897

    Google Scholar 

  41. D’Onofrio M, Zamboni G, Malago R et al (2009) Resectable pancreatic adenocarcinoma: is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol 35:1929–1937

    Article  PubMed  Google Scholar 

  42. D’Onofrio M, Zamboni G, Faccioli N et al (2007) Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181

    Article  PubMed  Google Scholar 

  43. D’Onofrio M, Martone E, Malago R et al (2007) Contrast enhanced ultrasonography of the pancreas. JOP 8(Suppl 1):71–76

    PubMed  Google Scholar 

  44. Faccioli N, D’Onofrio M, Zamboni G et al (2008) Resectable pancreatic adenocarcinoma, depiction of tumoral margins at contrast-enhanced ultrasonography. Pancreas 37:265–268

    Article  PubMed  Google Scholar 

  45. D’Onofrio M, Malago R, Zamboni G et al (2005) Contrast enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5:398–402

    Article  PubMed  Google Scholar 

  46. Kitano M, Kudo M, Maekawa K et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53:854–859

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. D’Onofrio M, Barbi E, Dietrich CF et al (2012) Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol 81(4):630–638

    Article  PubMed  Google Scholar 

  48. Numata K, Ozawa Y, Kobayashi N et al (2005) Contrast-enhanced sonography of pancreatic carcinoma, correlation with pathological findings. J Gastroenterol 40:631–640

    Article  PubMed  Google Scholar 

  49. Kloppel G, Schluter E (1999) Pathology of the pancreas. In: Baert AL, Delorme G, Van Hoe L (eds) Radiology of the pancreas, 2nd edn. Springer, Germany, pp 69–100

    Chapter  Google Scholar 

  50. Tunaci M (2004) Multidetector row CT of the pancreas. Eur J Radiol 52(1):18–30

    Article  PubMed  Google Scholar 

  51. McNulty NJ, Francis IR, Platt JF et al (2001) Multi-detector row helical CT of the pancreas, effect of contrast enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology 220(1):97–102

    Article  CAS  PubMed  Google Scholar 

  52. Lu DS, Vedantham S, Krasny RM et al (1996) Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures. Radiology 199:697–701

    Article  CAS  PubMed  Google Scholar 

  53. Boland GW, O’Malley ME, Saez M et al (1999) Pancreatic-phase versus portal vein-phase helical CT o the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605–606

    Article  CAS  PubMed  Google Scholar 

  54. Brennan DD, Zamboni GA, Raptopoulos VD et al (2007) Compre-hensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 27(6):1653–1666

    Google Scholar 

  55. Tabuchi T, Itoh K, Ohshio G et al (1999) Tumor staging of pancreatic adenocarcinoma using early- and late-phase helical CT. AJR Am J Roentgenol 173(2):375–380

    Article  CAS  PubMed  Google Scholar 

  56. Bluemke DA, Cameron JL, Hruban RH et al (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385

    Article  CAS  PubMed  Google Scholar 

  57. Bronstein YL, Loyer EM, Kaur H et al (2004) Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182:619–623

    Article  PubMed  Google Scholar 

  58. Diehl SJ, Lehmann KJ, Sadick M et al (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206:373–378

    Article  CAS  PubMed  Google Scholar 

  59. DeWitt J, Devereaux B, Chriswell M et al (2004) Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 141:753–763

    Article  PubMed  Google Scholar 

  60. Fusari M, Maurea S, Imbriaco M et al (2010) Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses. Radiol Med 115:453–466

    Article  CAS  PubMed  Google Scholar 

  61. Legmann P, Vignaux O, Dousset B et al (1998) Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 170:1315–1322

    Article  CAS  PubMed  Google Scholar 

  62. Agarwal B, Abu-Hamda E, Molke KL et al (2004) Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 99:844–850

    Article  PubMed  Google Scholar 

  63. D’Onofrio M, Crosara S, Signorini M et al (2013) Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinoma. Ultraschall Med 34(4):377–381

    Google Scholar 

  64. Baron RL (1994) Understanding and optimizing use of contrast material for CT of the liver. Am J Roentgenol 163:323–331

    Article  CAS  Google Scholar 

  65. Klauss M, Mohr A, von Tengg-Kobligk H et al (2008) A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography. Pancreatology 8:204–210

    Article  CAS  PubMed  Google Scholar 

  66. Karmazanovsky G, Fedorov V, Kubyshkin V et al (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488–500

    Article  CAS  PubMed  Google Scholar 

  67. Lu DS, Reber HA, Krasny RM et al (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439–1443

    Article  CAS  PubMed  Google Scholar 

  68. Roche CJ, Hughes ML, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180:475–480

    Article  PubMed  Google Scholar 

  69. Tamm EP, Silverman PM, Charnsangavej C et al (2003) Diagnosis, staging, and surveillance of pancreatic cancer. AJR Am J Roentgenol 180:1311–1323

    Article  PubMed  Google Scholar 

  70. Park MS, Klotz E, Kim MJ et al (2009) Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 250(1):110–117

    Article  PubMed  Google Scholar 

  71. Kambadakone AR, Sharma A, Catalano OA et al (2011) Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time. Eur Radiol 21(6):1293–1300

    Article  PubMed  Google Scholar 

  72. Miles KA (2003) Perfusion CT for the assessment of tumor vascularity: which protocol? Br J Radiol 76(1):S36–S42

    Article  PubMed  Google Scholar 

  73. Kandel S, Kloeters C, Meyer H et al (2009) Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results. Eur Radiol 19:2641–2646

    Article  PubMed  Google Scholar 

  74. Xu J, Liang Z, Hao S et al (2009) Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging. Abdom Imaging 34:759–766

    Article  PubMed  Google Scholar 

  75. D’Onofrio M, Gallotti A, Mantovani W et al (2013) Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma. Eur J Radiol 82(2):227–233

    Article  PubMed  Google Scholar 

  76. Hanninen EL, Pech M, Jonas S et al (2005) Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46:462–470

    Article  CAS  PubMed  Google Scholar 

  77. Hakime A, Giraud M, Vuillerme MP et al (2007) MR imaging of the pancreas. J Radiol 88:11–25

    Article  CAS  PubMed  Google Scholar 

  78. Matos C, Bali MA, Delhaye M et al (2006) Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Res Clin Gastroenterol 20:157–178

    Article  PubMed  Google Scholar 

  79. Kartalis N, Lindholm TL, Aspelin P et al (2009) Diffusion weighted magnetic resonance imaging of pancreas tumors. Eur Radiol 19:1981–1990

    Article  PubMed  Google Scholar 

  80. Nagakawa T, Mori K, Nakano T et al (1993) Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80:619–621

    Article  CAS  PubMed  Google Scholar 

  81. Drapiewski JF (1994) Carcinoma of the pancreas: a study of neoplastic invasion of nerves and its possible clinical significance. Am J Clin Pathol 14:549–556

    Google Scholar 

  82. Megibow AJ, Bosniak MA, Ambos MA et al (1981) Thickening of the celiac axis and/or superior mesenteric artery: a sign of pancreatic carcinoma on computed tomography. Radiology 141(2):449–453

    Article  CAS  PubMed  Google Scholar 

  83. Kardon DE, Thompson LD, Przygodzki RM et al (2001) Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol 14(5):443–451

    Article  CAS  PubMed  Google Scholar 

  84. Imaoka H, Shimizu Y, Mizuno N et al (2014) Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study. Pancreas 43(2):287–290

    Article  CAS  PubMed  Google Scholar 

  85. Regi P, Butturini G, Malleo G et al (2011) Clinicopathological features of adenosquamous pancreatic cancer. Langenbecks Arch Surg 396(2):217–222

    Article  PubMed  Google Scholar 

  86. Simone CG, Zuluaga Toro T, Chan E et al (2013) Characteristics and outcomes of adenosquamous carcinoma of the pancreas. Gastrointest Cancer Res 6(3):75–79

    PubMed Central  PubMed  Google Scholar 

  87. Adsay NV, Andea A, Weaver DC (2001) Centrally necrotic invasive ductal adenocarcinomas of the pancreas presenting clinically as macrocystic lesions. Mod Pathol 13:1125A

    Google Scholar 

  88. Lukás Z, Dvorák K, Kroupová I et al (2006) Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas. Pancreas 32(3):325–329

    Article  PubMed  Google Scholar 

  89. Paal E, Thompson LD, Frommelt RA et al (2001) A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diagn Pathol 5(3):129–140

    Article  CAS  PubMed  Google Scholar 

  90. Strobel O, Berens V, Hinz U et al (2012) Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer. Surgery 152(3 Suppl 1):S33–S42

    Article  PubMed  Google Scholar 

  91. Bergmann F, Esposito I, Michalski CW et al (2007) Early undifferentiated pancreatic carcinoma with osteoclastlike giant cells: direct evidence for ductal evolution. Am J Surg Pathol 31(12):1919–1925

    Article  PubMed  Google Scholar 

  92. Clark CJ, Arun JS, Graham RP et al (2014) Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. Am Surg 80(2):117–123

    PubMed  Google Scholar 

  93. Wilentz RE, Goggins M, Redston M et al (2000) Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 156(5):1641–1651

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  94. Kosmahl M, Pauser U, Peters K et al (2004) Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 445:168–178

    Article  CAS  PubMed  Google Scholar 

  95. Lee LY, Hsu HL, Chen HM et al (2003) Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. Int J Surg Pathol 11:235–239

    Article  PubMed  Google Scholar 

  96. Capelli P, Parisi A (2012) Pancreatic lesions: pathologic correlations. In: D’Onofrio M (ed) Ultrasonography of the pancreas. Springer, Italy, pp 165–186

    Chapter  Google Scholar 

  97. Prokesch RW, Chow LC, Beaulieu CF et al (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224:764–768

    Article  PubMed  Google Scholar 

  98. Yoon SH, Lee JM, Cho JY et al (2011) Small (<=20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 259:442–452

    Article  PubMed  Google Scholar 

  99. Kim JH, Park SH, Yu ES et al (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96

    Article  PubMed  Google Scholar 

  100. Barugola G, Partelli S, Marcucci S et al (2009) Resectable pancreatic cancer: who really benefits from resection? Ann Surg Oncol 16:3316–3322

    Article  PubMed  Google Scholar 

  101. Greenberg RE, Bank S, Stark B (1990) Adenocarcinoma of the pancreas producing pancreatitis and pancreatic abscess. Pancreas 5:108–113

    Article  CAS  PubMed  Google Scholar 

  102. D’Onofrio M, Zamboni G, Tognolini A et al (2006) Massforming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12:4181–4184

    PubMed Central  PubMed  Google Scholar 

  103. D’Onofrio M, Malago R, Martone E et al (2005) Pancreatic pathology. In: Quaia E (ed) Contrast media in ultrasonography. Springer, Berlin/Heidelberg, pp 335–347

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mirko D’Onofrio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Italia

About this chapter

Cite this chapter

D’Onofrio, M. et al. (2015). Ductal Adenocarcinoma. In: D'Onofrio, M., Capelli, P., Pederzoli, P. (eds) Imaging and Pathology of Pancreatic Neoplasms. Springer, Milano. https://doi.org/10.1007/978-88-470-5678-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5678-7_1

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5677-0

  • Online ISBN: 978-88-470-5678-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics